Ignite Creation Date:
2024-05-06 @ 7:24 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT06009848
Status:
RECRUITING
Last Update Posted:
2023-08-24
First Post:
2023-08-19
Brief Title:
Cadonilimab Plus Nab-Paclitaxel for Recurrent or Metastatic Muscle Invasive Bladder Cancer
Sponsor:
Tianjin Medical University Second Hospital
Organization:
Tianjin Medical University Second Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Bladder Cancer |
Keywords:
| Name | View |
|---|---|
| Muscle Invasive Bladder Cancer | View |